- Research
- Open access
- Published:
Multi-organ dysfunction and outcomes in pregnancy associated COVID-19 infection – descriptive review of pathological findings
BMC Pregnancy and Childbirth volume 24, Article number: 45 (2024)
Abstract
Objective(s)
Comparative clinical and morphological characterization of lesions of the vascular and nervous system in cases of maternal death associated with COVID-19.
Study design
The study included autopsy in 12 cases of maternal death with a positive intravital result for SARS-CoV-2 by reverse transcription polymerase chain reaction. For histopathology, tissue samples were taken from the internal organs of each patient. Pieces of organs were fixed and stained according to the standard protocol. The relative number of microvessels with vasculitis and fibers of the peripheral nervous system with infiltration by immune cells was studied. All morphological changes were classified depending on the severity of the damage.
Results
The average age of patients with a fatal outcome was 35 ± 4.4 years. Time to death after onset of symptoms averaged 16 ± 4.4 days. Dystrophic lesions (necrosis and apoptosis) of the villous and extravillous trophoblast and decidual tissue were observed in the studied placentas. Histopathological signs of mild and severe lesions of the peripheral nervous system in the organs of the gastrointestinal tract were detected in 2 (16.7%) and 10 (83.3%) cases, respectively, in the myocardium in 4 (33.3%) and 8 (66.7%) cases. Histopathological signs of severe damage to the microvascular bed in the organs of the gastrointestinal tract were registered in 9 (75%) cases.
Conclusion(s)
The main clinical feature of this cohort was that death occurred in a long-term period, in most cases with a negative PCR. The histopathological pattern was a non-acute injury with an immune component of the microvascular bed and the autonomic nervous system with predominant damage to the myocardium and intestines.
What does this study add to the clinical work
This study makes it possible to even better study the immunopathological profile in organs and tissues in pregnant women with a fatal outcome when affected by a viral infection, in particular Covid-19. This knowledge can be used when humanity encounters other viral pandemics in the future.
Introduction
COVID-19 (SARS-CoV-2) has been the cause of a pandemic and death worldwide for 2.5 years. COVID-19 has often been mild or asymptomatic in pregnant women, but severe and fatal cases have also been reported. Documentation of the histopathological features of the disease caused by SARS-CoV-2 is sparse in reported cases of maternal death. The pathogenesis of COVID-19 is not known: the proposed thanatogenesis involves immune-mediated mechanisms or direct effects of SARS-CoV-2 on tissues.
Pregnant women form a special group of patients with specific immunological and physiological changes [1,2,3]. Weakening of cell-mediated immune responses makes a pregnant woman more susceptible to infections caused by intracellular pathogens such as viruses [4]. Physiological changes during pregnancy have a significant impact on the respiratory, cardiovascular, and coagulation systems, which may have different effects on the progression of COVID-19 disease.
The impact of SARS-CoV-2 on pregnancy remains to be established, as the pathophysiological mechanisms are unclear, and the morphological patterns of damage to organs and organ systems are heterogeneous without signs of tissue and organ specificity. Previously, it was shown [5,6,7,8], that damage associated with COVID-19 is accompanied by damage to the vascular and peripheral nervous systems, histopathologically manifested by systemic multiple organ microvasculitis [9, 10].
The objective of our work was a comparative clinical and morphological characterization of lesions of the vascular and nervous system in cases of maternal death associated with COVID-19.
Methods
Study design
The study included 12 maternal deaths from COVID-19 with a positive intravital nasopharyngeal swab for SARS-CoV-2 using reverse transcription polymerase chain reaction that occurred in 2020–2021. An autopsy was performed in the pathoanatomical department. Lifetime testing for SARS-CoV-2 was performed by licensed medical laboratories using polymerase chain reaction (PCR) nasal and throat swab samples. The written informed consent of the next of kin was obtained for the autopsy. Clinical information and laboratory data were obtained from patients’ electronic health records.
Autopsy procedure and tissue processing
The autopsy took from 3 to 22 h (average 11 h) after death.
External examination, autopsy, and tissue sampling of all patients were performed in accordance with the latest recommendations for safety precautions in suspected or confirmed cases of COVID-19, including the use of masks, protective suits, and cut-resistant gloves. The autopsy was performed in accordance with the autopsy protocol developed in our organization in accordance with published guidelines [11,12,13]. In all cases, a complete autopsy was performed with a study of the brain, all organs of the chest and abdominal cavity.
For histopathology, tissue samples were taken from the internal organs of each patient, from which, after macroscopic evaluation, the most representative areas were selected. Photographs were taken and representative sections of all organs and clearly visible lesions were presented.
We fixed organ pieces in neutral buffered formalin (10%) and stained with hematoxylin & eosin according to the standard protocol. Two licensed pathologists fulfilled the histological examination of autopsy material.
Morphological study
The relative number of microvessels with vasculitis and fibers of the peripheral nervous system with infiltration by immune cells was assessed in histological sections.
All morphological changes were classified depending on the severity of the damage. The absence of morphological changes was classified as absent (no infiltration by immune cells), low (< 30% of vessels/nerve fibers) and high (> 30% of vessels/nerve fibers).
Descriptive statistics
Continuous data with a normal distribution were expressed as an average value ± standard deviation (SD), whereas continuous data with a nonnormal distribution were represented as a median (interquartile range). Categorical data were represented in a frequency (as a percentage).
Results
General cohort characteristics and the results of clinical and laboratory examination
The average age of patients with a fatal outcome was 35 ± 4.4 years. The most common initial symptoms were dyspnea, fever, and cough. Additional respiratory pathogens were isolated from two patients. The median time from symptom onset to hospitalization was 4 days (2.75–5.25). All patients were intubated. The median time from symptoms onset to intubation was 9 days (8.0–10.75). Time to death after symptoms onset ranged from 12 to 26 days, with the average value of 16 ± 4.4 days. In all cases, computed tomography showed bilateral multifocal diffuse ground-glass opacities to consolidation, with a median area of involvement of 52% (range 25–88%). Three patients had premature detachment of a normally located placenta. Characteristics of the cohort, clinical symptoms, and data from laboratory and instrumental studies are presented in Table 1.
Delivery was performed by caesarean section in all cases, in 3 cases – up to 37 weeks. Antenatal fetal death occurred in two patients, in one patient the child died on the 5th day after birth (respiratory distress syndrome, critically low body weight). The average weight of full-term newborns was 3108 g. The duration of neonatal hospitalization varied from 4 to 55 days. Pneumonia/sepsis of the newborn was observed in 5 cases. Perinatal outcomes for maternal deaths following confirmed SARS-CoV-2 infection are presented in Table 2.
Severe edematous lungs were revealed at autopsy in all the dead, the average weight for the right lung was 1439 g, for the left lung – 950 g. The lung tissue was heavy and hard, uneven bluish-red color with diffuse hemorrhages. The volume of pleural fluid varied greatly and ranged from 0 to 350 ml per pleural cavity. Histopathological examination of the respiratory system demonstrated a pattern of diffuse alveolar injury in 100% of patients, as evidenced by the presence of intraalveolar fibrin, hyaline membranes, or organizing connective tissue in the alveolar septa. Patterns of acute (exudative) and organizing (proliferative) diffuse alveolar lesions were identified in 10 (83.3%) of 12 patients with diffuse alveolar lesions.
Alveolar hemorrhagic syndrome with diffuse alveolar damage was identified in 8 (66.7%) of 12 patients. All patients demonstrated heterogeneous patterns of acute and subacute injury with marked perivascular lymphocytic infiltration. Foci of acute purulent inflammation were also determined: focal bronchial or bronchoalveolar inflammation was revealed in 3 patients. Focal pulmonary microthrombi were detected in 10 (83.3%) patients.
Gastrointestinal pathological findings in the liver showed mild periportal lymphocytic inflammation, focal centrilobular necrosis consistent with hypoperfusion injury. Nonspecific acute histopathological changes were detected in the large and small intestines, including mucosal edema, erosions and focal necrosis. All patients demonstrated heterogeneous patterns of microvasculature damage of varying severity, including infiltration of the vessel wall by immune cells.
Acute and subacute ischemic changes were revealed in the brain, including destructive changes in nerve cells such as swelling, vacuolization, karyolysis and perivascular glial hyperplasia. All patients except №3 and №4 had vasculitis of varying severity.
Non-specific acute histopathological changes and damage to the microvasculature and peripheral nervous system were found in the myocardium, including infiltration by immune cells and chronic damage (perivascular sclerosis and lipomatosis, focal hypertrophy of cardiomyocytes). An organized thrombus was diagnosed in the heart in patient №7.
Signs suggestive of acute tubular injury, including extensive vacuolization of the tubular epithelium, have been identified in the kidneys.
Severe dystrophic changes in the myometrium, myonecrosis, microthrombi and vasculitis in the uterus were detected in 11 cases. The uterus was not found at autopsy in 1 case (patient №8), as it was removed during a caesarean section due to atony.
Dystrophic lesions (necrosis and apoptosis) of the villous and extravillous trophoblast and decidual tissue were observed in the studied placentas: lymphocytic vasculitis, perivascular lymphocytic clutches and vasculitis in the area of the placental bed with a high degree of endothelial damage (pronounced edema and swelling, desquamation of the endothelium from the basal plate, apoptosis, necrosis), thrombi of the intervillous space. In 1 case (patient №1), acute intervillositis with obliteration of the intervillous space was detected. Histological findings for individual patients are presented in Table 3.
Histopathological pattern of microvascular lesions
Histopathological patterns of mild and severe lesions of the microvascular bed were found in the organs of the respiratory system in 3(25.0%) and 9(75.0%) cases.
Vasculitis of microvessels was not detected in the organs of the gastrointestinal tract or occupied less than 30% of the vessels in 3(25.0%) cases. Immune cells affected more than 30% of microvasculature vessels in 9(75%) cases.
Histopathological signs of damage to the microvasculature in the organs of the central nervous system were not detected in 5(41.6%) cases, the histopathological pattern of mild microvascular damage was detected in 7(58.3%) cases.
Microvascular vasculitis in the myocardium was not detected in 4(33.3%) cases, microvascular vasculitis occupied less than 30% of the vessels in 5(41.69%) cases. Histopathological pattern of severe microvascular damage was found in 3(25.01%) cases.
Histopathological pattern of lesions in the peripheral nervous system
Histopathological signs of mild and severe damage to the peripheral nervous system in the organs of the gastrointestinal tract were detected in 2(16.7%) and 10(83.3%) cases.
Fibers of the peripheral nervous system with infiltration by immune cells, damaging less than 30% of the fibers, were found in the myocardium in 4(33.3%) cases, fibers of the peripheral nervous system with infiltration by immune cells, damaging more than 30% of the fibers, in 8(66, 6%) cases.
Discussion
Principal findings
The spectrum of pathology in people dying from COVID-19 is just beginning to emerge [14,15,16]. We present a case series of 12 maternal deaths following confirmed SARS-CoV-2 infection. Our results demonstrate an important role in the mechanism of thanatogenesis in severe SARS-CoV-2 infection in capillary and neurotrophic insufficiency of internal organs and provide evidence-indicating damage to microvessels and the peripheral nervous system by immune cells.
An important histopathological finding is the fact that in all the presented cases, non-specific damage to microvessels (vasculitis by immune cells) and the peripheral nervous system (perineural edema with intranerval infiltration by immune cells) with selective damage to the myocardium and intestines was found. Moderate or severe perivascular mononuclear chronic inflammatory cell aggregates were observed in almost all cases. Severe injuries were associated with a longer course of the disease, in some cases with multiple negative PCR results in the long-term period. This morphological picture may be a substrate for progressive multiple organ failure, which partly explains the mechanisms of thanatogenesis in «non-recovering» patients. Longer follow-up may be important, as most of our patients have died within days or weeks of first symptoms and often in the postpartum period.
The direct cause of death of patients was multiple organ failure with subsequent negative PCR in 9(75%) cases. In a morphological study, we found that a fatal outcome after a confirmed infection with SARS-CoV-2 was often associated with diffuse microvascular and neurotrophic insufficiency, the morphological substrate of which was the infiltration of microvascular walls and fibers of the peripheral nervous system by immune cells with the predominant involvement of myocardial and intestinal tissues. The selectivity of damage remains debatable and requires further research. In the long term, this process can lead to severe damage with an autoimmune component.
Clinical implications
The histopathological picture of the uteroplacental complex was characterized by diffuse damage to the placental link (necrosis and apoptosis of the villous and extravillous trophoblast, thrombi in the intervillous space, vasculitis). In the study cohort, a high incidence of PDNLP was observed – 3(25.0%) cases. It is not excluded that an additional factor that increased the risk of PDNLP in this case could be apoptosis of the chorionic and decidual tissue due to SARS CoV-2 infection. It is likely that apoptosis is associated with direct viral (cytopathic) or secondary (hypoxic) damage. The pathogenesis of the damage is most likely as follows: apoptosis of villous and extravillous trophoblast cells, combined with necrosis due to hypoxic damage caused by systemic endotheliitis, promotes the production of prostaglandins and the release of cytokines, which increases uterine contractions and leads to placental abruption. This assumption requires the further research.
Results in the context of what is known
As in previously published scientific studies [17, 18], the histopathological observation in our series of patients who died from COVID-19 was diffuse alveolar lung disease with a heterogeneous mosaic pattern in the acute (exudative) and organizational (proliferative) phases. This lesion was also observed in a patient who died in 4 days after hospitalization, suggesting that lung injury in patients with COVID-19 may be subclinical and clinically relevant for the identification and management of patients with diffuse alveolar injury.
We observed a difference in the average age of the mother in our case series compared with other cohorts [19], the average age of the deceased was higher in our cohort.
The clinical significance of this difference is unknown. The presence in 3 cases of comorbidities that increase the population risk (diabetes mellitus, gestational diabetes mellitus, chronic arterial hypertension, hypothyroidism) and preeclampsia is an additional factor that should be taken into account when interpreting the results of this study. Similarly, we consider it unlikely that the quality of obstetric care provided could have contributed to poor outcomes.
All 12 maternal deaths associated with COVID-19 infection occurred in women who had never received a dose of the COVID-19 vaccine. Our case series is consistent with studies indicating that severe SARS-CoV-2 infection increases the risk of maternal death in unvaccinated women [20,21,22,23].
Research implications
The findings require further clinical and morphological studies of the immunopathological process as a pathophysiological process of inflammatory damage to the microvascular bed and peripheral nervous system with an immune component. The important clinical significance of this fact lies in the need to develop new strategies for managing such cases in confirmed SARS-CoV-2 infection.
Strengths and limitations
Our study has limitations. The number of cases studied was limited to 12 patients, further studies will show whether the relatively consistent results of this study of a small number of patients are consistent with larger cohorts.
Conclusions
The results of our studies have shown that the histology of microvessels and fibers of the peripheral nervous system demonstrates pathological changes (infiltration by immune cells) in cases of maternal death associated with COVID-19. The main clinical feature of this cohort was that death occurred in a long-term period, in most cases with a negative PCR. The main clinical and morphological complex was microvascular and neurotrophic insufficiency of internal organs (clinically - multiple organ failure). The histopathological pattern was a non-acute injury with an immune component of the microvascular bed and the autonomic nervous system with predominant damage to the myocardium and intestines.
Data availability
All data generated or analysed during this study are included in this published article (and its supplementary information files-Tables).
References
Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–33.
Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33(10 Suppl):390–S397.
Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122.
Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12(11):1638–43.
Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol. 2020;267(6):1573–6.
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90.
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of Coronavirus Disease 2019: a review. JAMA Neurol. 2020;77(8):1018–27.
Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–83.
Ding YQ, Bian XW. Zhonghua Bing Li Xue Za Zhi. 2020;49(4):291–3.
Wang HJ, Du SH, Yue X, Chen CX. Review and Prospect of pathological features of Corona Virus Disease. Fa Yi Xue Za Zhi. 2020;36(1):16–20.
Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198–209.
Autopsy Committee releases COVID-19 Autopsy Guideline Statement. College of American Pathologists. Published May 5, 2020. Updated February 2., 2021. Accessed February 4, 2021.
World Health Organization. Infection Prevention and Control for the safe management of a dead body in the context of COVID-19. 2020. https://apps.who.int/iris/bitstream/handle/10665/331538/WHO-COVID-19-lPC_DBMgmt-2020.1-eng.pdf. Accessed 08 Aug 2020.
Sanguedolce F, Zanelli M, Ascani S, et al. SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications. Panminerva Med. 2022;64(1):80–95.
Suess C, Hausmann R. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation. Int J Legal Med. 2020;134(4):1285–90.
Tombolini A, Scendoni R. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns. Int J Legal Med. 2020;134(6):2205–8.
Konopka KE, Nguyen T, Jentzen JM, et al. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 infection is morphologically indistinguishable from other causes of DAD. Histopathology. 2020;77(4):570–8.
Sauter JL, Baine MK, Butnor KJ, et al. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies. Histopathology. 2020;77(6):915–25.
La Verde M, Riemma G, Torella M, et al. Maternal death related to COVID-19: a systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics. Int J Gynaecol Obstet. 2021;154(2):212–9.
Villar J, Soto Conti CP, Gunier RB, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023;401(10375):447–57.
Birol Ilter P, Prasad S, Mutlu MA, et al. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves. Ultrasound Obstet Gynecol. 2022;60(1):96–102.
Engjom HM, Ramakrishnan R, Vousden N, et al. Severity of maternal SARS-CoV-2 infection and perinatal outcomes of women admitted to hospital during the omicron variant dominant period using UK Obstetric Surveillance System data: prospective, national cohort study. BMJ Med. 2022;1(1):e000190. Published 2022 Aug 24.
Ellington S, Jatlaoui TC. COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy. Lancet. 2023;401(10375):412–3.
Acknowledgements
Not applicable.
Funding
This research has been funded by the Ministry of Health of the Republic of Kazakhstan №BR11065386.
Author information
Authors and Affiliations
Contributions
Turdybekova collected clinical data and wrote the main text of the article; Kamyshanskiy carried out a pathomorphological description of glass preparations and writing the main text of the article; Kopobaeyva prepared Tables 1, 2 and 3, analyzed the data; Turmukhambetova developed the study design. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
The study was approved by the Ethical Commission of NJSC “Karaganda Medical University” Protocol No. 18 dated April 14, 20, assigned number 64, the requirements of national legislation were observed during the studies. The written informed consent of the next of kin was obtained for the autopsy.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Turdybekova, Y., Kopobayeva, I., Turmukhambetova, A.A. et al. Multi-organ dysfunction and outcomes in pregnancy associated COVID-19 infection – descriptive review of pathological findings. BMC Pregnancy Childbirth 24, 45 (2024). https://doi.org/10.1186/s12884-023-06240-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12884-023-06240-x